Related references
Note: Only part of the references are listed.Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNα/β and IL-1β responses in the diseased brain and exacerbates chronic neurodegeneration
Robert Field et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction
Keigan M. Park et al.
CELLULAR SIGNALLING (2010)
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
Cameron R. Stewart et al.
NATURE IMMUNOLOGY (2010)
Elevated Ratio of Urinary Metabolites of Thromboxane and Prostacyclin Is Associated with Adverse Cardiovascular Events in ADAPT
Thomas J. Montine et al.
PLOS ONE (2010)
Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2
J. A. Sloane et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Key Role of CD36 in Toll-Like Receptor 2 Signaling in Cerebral Ischemia
Takato Abe et al.
STROKE (2010)
Toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation
Hanna Kalvegren et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Protection of Hippocampal Neurogenesis from Toll-Like Receptor 4-Dependent Innate Immune Activation by Ablation of Prostaglandin E2 Receptor Subtype EP1 or EP2
C. Dirk Keene et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Tumour Necrosis Factor Modulation for Treatment of Alzheimer's Disease Rationale and Current Evidence
Edward Tobinick
CNS DRUGS (2009)
Toll-Like Receptor Prestimulation Increases Phagocytosis of Escherichia coli DH5 alpha and Escherichia coli K1 Strains by Murine Microglial Cells
Sandra Ribes et al.
INFECTION AND IMMUNITY (2009)
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Erin G. Reed-Geaghan et al.
JOURNAL OF NEUROSCIENCE (2009)
Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology
Henrieta Scholtzova et al.
JOURNAL OF NEUROSCIENCE (2009)
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
Mauricio F. Farez et al.
NATURE IMMUNOLOGY (2009)
Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology
Fiona E. McAlpine et al.
NEUROBIOLOGY OF DISEASE (2009)
β-Glucan attenuates TLR2-and TLR4-mediated cytokine production by microglia
Vaibhav B. Shah et al.
NEUROSCIENCE LETTERS (2009)
Regulation of innate immune responses in the brain
Serge Rivest
NATURE REVIEWS IMMUNOLOGY (2009)
Chronic Neuron-Specific Tumor Necrosis Factor-Alpha Expression Enhances the Local Inflammatory Environment Ultimately Leading to Neuronal Death in 3xTg-AD Mice
Michelle C. Janelsins et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Therapeutic targets in prostaglandin E2 signaling for neurologic disease
P. J. Cimino et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer's Disease
Malabendu Jana et al.
JOURNAL OF IMMUNOLOGY (2008)
Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease
Jing-Ji Jin et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration
Hui-Ming Gao et al.
JOURNAL OF NEUROSCIENCE (2008)
Synuclein activates microglia in a model of Parkinson's disease
Xiaomin Su et al.
NEUROBIOLOGY OF AGING (2008)
Protective effects of NSAIDs on the development of Alzheimer disease
Steven C. Vlad et al.
NEUROLOGY (2008)
Prevention of Alzheimer's disease
C. A. Szekely et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2007)
Involvement of prostaglandin E2 in production of amyloid-β peptides both in vitro and in vivo
Tatsuya Hoshino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
TLR3-dependent induction of nitric oxide synthase in RAW 264.7 macrophage-like cells via a cytosolic phospholipase A2/cyclooxygenase-2 pathway
Jose Pindado et al.
JOURNAL OF IMMUNOLOGY (2007)
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting
Youfei Guan et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses
Uwe Koedel et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats
Angela B. Reksidler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Liya Qin et al.
GLIA (2007)
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
Jinghua Jin et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Toll-like receptor 2 signaling in response to brain injury: An innate bridge to neuroinflammation
Alicia A. Babcock et al.
JOURNAL OF NEUROSCIENCE (2006)
α-synuclein expression modulates microglial activation phenotype
Susan A. Austin et al.
JOURNAL OF NEUROSCIENCE (2006)
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease
Melissa K. McCoy et al.
JOURNAL OF NEUROSCIENCE (2006)
Comparative study of microglia activation induced by amyloid-beta and prion peptides:: Role in neurodegeneration
Pedro Garcao et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Trial of celecoxib in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
ANNALS OF NEUROLOGY (2006)
Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity:: role of TNF-α
Krishnan Sriram et al.
FASEB JOURNAL (2006)
TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: Differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression
C Park et al.
GLIA (2006)
Prostaglandin E2 EP1 receptors:: downstream effectors of COX-2 neurotoxicity
T Kawano et al.
NATURE MEDICINE (2006)
Levels of CSF prostaglandin E-2, cognitive decline, and survival in Alzheimer's disease
M Combrinck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Clinical aspects of inflammation in Alzheimer's disease
PB Rosenberg
INTERNATIONAL REVIEW OF PSYCHIATRY (2006)
Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease
XB Liang et al.
JOURNAL OF NEUROSCIENCE (2005)
Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity
FS Shie et al.
GLIA (2005)
TLR signaling tailors innate immune responses in human microglia and astrocytes
CS Jack et al.
JOURNAL OF IMMUNOLOGY (2005)
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment
LJ Thal et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Ibuprofen suppresses interleukin-1β induction of pro-amyloidogenic α1-antichymotrypsin to ameliorate β-amyloid (Aβ) pathology in Alzheimer's models
T Morihara et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice
LM Billings et al.
NEURON (2005)
Inflammatory process in Parkinson's disease: Role for cytokines
T Nagatsu et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Genetic ablation of tumor necrosis factor-alpha (TNF-α) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum
B Ferger et al.
JOURNAL OF NEUROCHEMISTRY (2004)
mRNA is an endogenous ligand for Toll-like receptor 3
K Karikó et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
JK Olson et al.
JOURNAL OF IMMUNOLOGY (2004)
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
AN Hata et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation
YJ Chang et al.
MOLECULAR PHARMACOLOGY (2004)
Tumor necrosis factor-α, interleukin-1β, and interferon-γ stimulate γ-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway
YF Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
HL Chen et al.
ARCHIVES OF NEUROLOGY (2003)
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial
PS Aisen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
P Teismann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS
DB Drachman et al.
ANNALS OF NEUROLOGY (2002)
Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra
ZH Feng et al.
NEUROSCIENCE LETTERS (2002)
Indomethacin protects against neurodegeneration caused by MPTP intoxication in mice
I Kurkowska-Jastrzebska et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice
GP Lim et al.
NEUROBIOLOGY OF AGING (2001)
Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology
G Mehlhorn et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2000)
Share Paper
